LONG-TERM AND LATE EFFECTS OF CHEMOTHERAPY IN CHILDHOOD ACLEUKEMIA AND THEIR MANAGEMENT SINGLE INSTITUTION OBSERVATIONUTE LYMPHOBLASTIC
Introduction: Acute Lymphoblastic Leukemia (ALL) remains the most common malignant disease of childhood, accounting for approximately 26% of pediatric oncology diagnoses. Modern treatment approaches, particularly multi-agent chemotherapy regimens such as the BFM protocol, have significantly improved...
Saved in:
| Main Author: | Konul Baghirova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001853 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Late-effects of Chemoradiotherapy on Growth and Puberty in Survivors of Childhood Acute Lymphoblastic Leukemia
by: Sevgi Bilgiç Eltan, et al.
Published: (2022-12-01) -
A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia
by: Paige Johnson, et al.
Published: (2025-07-01) -
Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia.
by: Stefan Essig, et al.
Published: (2012-01-01) -
Long-term results of Berlin-Frankfurt-Muenster based therapy for childhood and adolescents’ lymphoblastic lymphoma
by: S. S. Kulikova, et al.
Published: (2022-11-01) -
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
by: Andrew D. Hughes, et al.
Published: (2025-01-01)